|
|
|
|
| LEADER |
00000cam a2200000 4500 |
| 001 |
EBOOKCENTRAL_on1024284552 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr |n|---||||| |
| 008 |
180224s2017 dcu ob 001 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d CUY
|d OCLCO
|d ZCU
|d MERUC
|d ICG
|d OCLCF
|d DKC
|d OCLCQ
|d SDF
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
| 020 |
|
|
|a 9781615371709
|
| 020 |
|
|
|a 1615371702
|
| 020 |
|
|
|z 9781615370832
|
| 035 |
|
|
|a (OCoLC)1024284552
|
| 050 |
|
4 |
|a RC568.O45
|b .O345 2018
|
| 082 |
0 |
4 |
|a 615/.7822
|2 23
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Renner, John A., Jr.
|
| 245 |
1 |
0 |
|a Office-Based Buprenorphine Treatment of Opioid Use Disorder.
|
| 250 |
|
|
|a 2nd ed.
|
| 260 |
|
|
|a Washington, D.C. :
|b American Psychiatric Publishing,
|c 2017.
|
| 300 |
|
|
|a 1 online resource (398 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Cover; Half Title; Title Page; Copyright; Contents; Contributors; Dedication; Foreword; Obtaining the Buprenorphine Waiver; 1 Opioid Use Disorder in America: HISTORY AND OVERVIEW; 2 General Opioid Pharmacology; 3 Efficacy and Safety of Buprenorphine; 4 Patient Assessment; 5 Clinical Use of Buprenorphine; 6 Buprenorphine Treatment in Office-Based Settings; 7 Psychosocial and Supportive Treatment; 8 Referral, Logistics, and Diversion; 9 Methadone, Naltrexone, and Naloxone; 10 Psychiatric Comorbidity; 11 Medical Comorbidity; 12 Acute and Chronic Pain; 13 Opioid Use by Adolescents.
|
| 505 |
8 |
|
|a 14 Womenâ#x80;#x99;s Health and Pregnancy15 Comments on the Case Vignettes; Appendix 1 Useful Web Sites and Recommended Readings; Appendix 2 Buprenorphine and Office-Based Treatment of Opioid Use Disorder Supplemental Materials; Index; Back Cover.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Opioid abuse
|x Chemotherapy.
|
| 650 |
|
0 |
|a Buprenorphine
|x Therapeutic use.
|
| 650 |
|
6 |
|a Toxicomanie aux opiacés
|x Chimiothérapie.
|
| 650 |
|
6 |
|a Buprénorphine
|x Emploi en thérapeutique.
|
| 650 |
|
7 |
|a Buprenorphine
|x Therapeutic use
|2 fast
|
| 650 |
|
7 |
|a Opioid abuse
|x Chemotherapy
|2 fast
|
| 700 |
1 |
|
|a Levounis, Petros.
|
| 700 |
1 |
|
|a LaRose, Anna T.
|
| 758 |
|
|
|i has work:
|a Handbook of office-based buprenorphine treatment of opioid dependence (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCFMqyd4vgvYqHrdXtjgPKm
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Renner, John A., Jr.
|t Office-Based Buprenorphine Treatment of Opioid Use Disorder.
|d Washington, D.C. : American Psychiatric Publishing, ©2017
|z 9781615370832
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=5294185
|z Texto completo
|
| 936 |
|
|
|a BATCHLOAD
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL5294185
|
| 994 |
|
|
|a 92
|b IZTAP
|
